PT  - JOURNAL ARTICLE
AU  - Albani, Vinicius
AU  - Loria, Jennifer
AU  - Massad, Eduardo
AU  - Zubelli, Jorge P.
TI  - COVID-19 Underreporting and its Impact on Vaccination Strategies
AID  - 10.1101/2021.03.11.21253404
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.03.11.21253404
4099  - http://medrxiv.org/content/early/2021/03/15/2021.03.11.21253404.short
4100  - http://medrxiv.org/content/early/2021/03/15/2021.03.11.21253404.full
AB  - We present a novel methodology for the stable rate estimation of hospitalization and death related to the Corona Virus Disease 2019 (COVID-19) using publicly available reports from various distinct communities. These rates are then used to estimate underreported infections on the corresponding areas by making use of reported daily hospitalizations and deaths. The impact of underreporting infections on vaccination strategies is estimated under different disease-transmission scenarios using a Susceptible-Exposed-Infective-Removed-like (SEIR) epidemiological model.One sentence Summary Using a novel methodology, we estimate COVID-19 underreporting from public data, quantifying its impact on vaccination.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [grant numbers 305544/2011-0 and 307873/2013-7], the Fundacao Butantan [grant number 01/2020], the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro [grant number E-26/202.927/2017], and the Universidad de Costa Rica (UCR)[grantnumberOAICE-CAB-02-022-2016].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This does not apply.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data used in this study came from public sources.